202 related articles for article (PubMed ID: 11563979)
1. A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor.
Ghiselli G; Eichstetter I; Iozzo RV
Biochem J; 2001 Oct; 359(Pt 1):153-63. PubMed ID: 11563979
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor.
LaRochelle WJ; Sakaguchi K; Atabey N; Cheon HG; Takagi Y; Kinaia T; Day RM; Miki T; Burgess WH; Bottaro DP
Biochemistry; 1999 Feb; 38(6):1765-71. PubMed ID: 10026256
[TBL] [Abstract][Full Text] [Related]
3. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
Sharma B; Handler M; Eichstetter I; Whitelock JM; Nugent MA; Iozzo RV
J Clin Invest; 1998 Oct; 102(8):1599-608. PubMed ID: 9788974
[TBL] [Abstract][Full Text] [Related]
4. Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor.
Berman B; Ostrovsky O; Shlissel M; Lang T; Regan D; Vlodavsky I; Ishai-Michaeli R; Ron D
J Biol Chem; 1999 Dec; 274(51):36132-8. PubMed ID: 10593896
[TBL] [Abstract][Full Text] [Related]
5. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7.
Mongiat M; Taylor K; Otto J; Aho S; Uitto J; Whitelock JM; Iozzo RV
J Biol Chem; 2000 Mar; 275(10):7095-100. PubMed ID: 10702276
[TBL] [Abstract][Full Text] [Related]
6. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.
Aviezer D; Iozzo RV; Noonan DM; Yayon A
Mol Cell Biol; 1997 Apr; 17(4):1938-46. PubMed ID: 9121441
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells.
Palmieri C; Roberts-Clark D; Assadi-Sabet A; Coope RC; O'Hare M; Sunters A; Hanby A; Slade MJ; Gomm JJ; Lam EW; Coombes RC
J Endocrinol; 2003 Apr; 177(1):65-81. PubMed ID: 12697038
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-binding protein is a novel partner for perlecan protein core.
Mongiat M; Otto J; Oldershaw R; Ferrer F; Sato JD; Iozzo RV
J Biol Chem; 2001 Mar; 276(13):10263-71. PubMed ID: 11148217
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
10. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
[TBL] [Abstract][Full Text] [Related]
11. Electrophoretic, biosensor, and bioactivity analyses of perlecans of different cellular origins.
Knox S; Melrose J; Whitelock J
Proteomics; 2001 Dec; 1(12):1534-41. PubMed ID: 11747213
[TBL] [Abstract][Full Text] [Related]
12. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
[TBL] [Abstract][Full Text] [Related]
13. A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells.
Mathiak M; Yenisey C; Grant DS; Sharma B; Iozzo RV
Cancer Res; 1997 Jun; 57(11):2130-6. PubMed ID: 9187109
[TBL] [Abstract][Full Text] [Related]
14. Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma.
Jayson GC; Vives C; Paraskeva C; Schofield K; Coutts J; Fleetwood A; Gallagher JT
Int J Cancer; 1999 Jul; 82(2):298-304. PubMed ID: 10389767
[TBL] [Abstract][Full Text] [Related]
15. The core protein of growth plate perlecan binds FGF-18 and alters its mitogenic effect on chondrocytes.
Smith SM; West LA; Hassell JR
Arch Biochem Biophys; 2007 Dec; 468(2):244-51. PubMed ID: 17971291
[TBL] [Abstract][Full Text] [Related]
16. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis.
Aviezer D; Hecht D; Safran M; Eisinger M; David G; Yayon A
Cell; 1994 Dec; 79(6):1005-13. PubMed ID: 7528102
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan.
Marchisone C; Del Grosso F; Masiello L; Prat M; Santi L; Noonan DM
Pathol Oncol Res; 2000; 6(1):10-7. PubMed ID: 10749582
[TBL] [Abstract][Full Text] [Related]
18. Epidermal transformation leads to increased perlecan synthesis with heparin-binding-growth-factor affinity.
Tapanadechopone P; Tumova S; Jiang X; Couchman JR
Biochem J; 2001 Apr; 355(Pt 2):517-27. PubMed ID: 11284741
[TBL] [Abstract][Full Text] [Related]
19. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
[TBL] [Abstract][Full Text] [Related]
20. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
